GURUFOCUS.COM » STOCK LIST » Technology » Software » Cellgentek Co Ltd (XKRX:258250) » Definitions » Capex-to-Revenue

Cellgentek Co (XKRX:258250) Capex-to-Revenue : 0.19 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Cellgentek Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Cellgentek Co's Capital Expenditure for the six months ended in Dec. 2023 was ₩-2,660.57 Mil. Its Revenue for the six months ended in Dec. 2023 was ₩14,404.10 Mil.

Hence, Cellgentek Co's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.19.


Cellgentek Co Capex-to-Revenue Historical Data

The historical data trend for Cellgentek Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellgentek Co Capex-to-Revenue Chart

Cellgentek Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
0.51 0.25 0.16 0.13 0.19

Cellgentek Co Semi-Annual Data
Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue 0.51 0.25 0.16 0.13 0.19

Competitive Comparison of Cellgentek Co's Capex-to-Revenue

For the Information Technology Services subindustry, Cellgentek Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cellgentek Co's Capex-to-Revenue Distribution in the Software Industry

For the Software industry and Technology sector, Cellgentek Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cellgentek Co's Capex-to-Revenue falls into.



Cellgentek Co Capex-to-Revenue Calculation

Cellgentek Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2660.574) / 14404.1
=0.18

Cellgentek Co's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2660.574) / 14404.1
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cellgentek Co  (XKRX:258250) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Cellgentek Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cellgentek Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cellgentek Co Business Description

Traded in Other Exchanges
N/A
Address
579-4 Yuseong-daero, Yuseong-gu, Daejeon, KOR
Cellgentek Co Ltd is engaged in provision of information technology services for IT venture companies including computer, IT software development and franchise business. It is also engaged in development of drugs.

Cellgentek Co Headlines

No Headlines